This document discusses chronic kidney disease (CKD) including its causes, stages, signs and symptoms, and treatment options. The leading causes of CKD in the US are diabetic nephropathy, hypertension, and glomerulonephritis. CKD is staged based on declining kidney function and glomerular filtration rate. Later stages involve more severe symptoms and complications. Treatment for stage 5 CKD may include hemodialysis, peritoneal dialysis, or kidney transplantation to replace kidney function and remove waste from the blood. Nutrition therapy and dietary modifications are also important parts of CKD management.
This document discusses chronic kidney disease (CKD) including its causes, stages, signs and symptoms, and treatment options. The leading causes of CKD in the US are diabetic nephropathy, hypertension, and glomerulonephritis. CKD is staged based on declining kidney function and glomerular filtration rate. Later stages involve more severe symptoms and complications. Treatment for stage 5 CKD may include hemodialysis, peritoneal dialysis, or kidney transplantation to replace kidney function and remove waste from the blood. Nutrition therapy and dietary modifications are also important parts of CKD management.
This document discusses chronic kidney disease (CKD) including its causes, stages, signs and symptoms, and treatment options. The leading causes of CKD in the US are diabetic nephropathy, hypertension, and glomerulonephritis. CKD is staged based on declining kidney function and glomerular filtration rate. Later stages involve more severe symptoms and complications. Treatment for stage 5 CKD may include hemodialysis, peritoneal dialysis, or kidney transplantation to replace kidney function and remove waste from the blood. Nutrition therapy and dietary modifications are also important parts of CKD management.
7" 8&(3'+9& ).& /.0(+121,+3*2 45$3)+1$( 14 ).& 6+%$&0(" The piimaiy physiological function of the kiuneys involves the maintenance of homeostasis thiough contiol of fluiu, pB, electiolyte balance anu bloou piessuie. 0iination anu souium iegulation aie key components of maintaining noimal homeostasis. Auuitionally, the kiuneys aie iesponsible foi piouuction of hoimones anu enzymes; anu the excietion of metabolic enu piouucts anu foieign substances.
:" ;.*) %+(&*(&(<31$%+)+1$( 3*$ 2&*% )1 3.'1$+3 6+%$&0 %+(&*(& =>?8@A Biabetic nephiopathy is the leauing cause of chionic kiuney uisease in the 0niteu States. Bypeitension anu glomeiulonephiitis aie also veiy common causes anu iisk factois associateu with the uisease. Stages of CKB Besciiption Signs anu Symptoms 1 Kiuney uamage with noimal oi incieaseu uFR (> 6u mLmin1.7Sm 2 ) 0sually no abnoimal physical symptoms, slightly elevateu seium cieatinine, anu abnoimal uiinalysis iesults. 2 Nilu ueciease in uFR (>9u mLmin1.7Sm 2 ) 0sually no abnoimal physical symptoms, slightly elevateu seium cieatinine, anu abnoimal uiinalysis iesults. S Noueiate ueciease in uFR (Su-S9mLmin1.7Sm 2 ) Tiieuness oi fatigue, puffiness oi swelling, back pain, changes in appetite, high bloou piessuie, changes in uiination (amount, fiequency, coloi), high seium cieatinine 4 Seveie ueciease in uFR (1S-29 mLmin1.7Sm 2 ) Tiieuness oi fatigue, puffiness oi swelling, back pain, changes in appetite, high bloou piessuie, changes in uiination (amount, fiequency, coloi), high seium cieatinine S Kiuney failuie (uialysis oi uFR <1SmLmin1.7Sm 2 ) Anemia, heauache, fatigue anu uiowsiness, weakness, nausea, thiist, muscle 2
B" CD/2*+$ .1E )0/& : %+*9&)&( F&22+)5( 3*$ 2&*% )1 >?8" 0ntieateu type 2 uiabetes can leau to CKB uue to uncontiolleu bloou sugais. In most cases, uiabetes causes high bloou sugai levels which leaus to a thickening in the glomeiulus anu a change in the membiane of the tissue. As the glomeiulai change occui, the glomeiulus is not able to efficiently filtei the bloou anu the fluius that foims uiine. As a iesult, the kiuney slowly begins allowing moie albumin to be excieteu in the uiine. The numbei of functioning nephions slowly ueclines anu the existing nephions cannot cleai the giowing solute loau. This causes concentiations in bouy fluius to inciease anu leaus to azotemia anu uiemia. The kiuneys piogiessively lose excietoiy, enuociine, anu metabolic functions, iesulting in chionic kiuney uisease.
! The founuation foi IgA Nephiopathy, (2uu2). Chionic Renal Insufficiency.
J" K'1F 015' '&*%+$, 14 L'(" M1*N5+$O( .+()1'0 *$% /.0(+3*2I E.*) (+,$( *$% (0F/)1F( %+% (.& .*P&A Nis. }oaquin weighs 17u pounus with a height of S'u" inuicating that she is oveiweight. She has high bloou piessuie, anu euema in extiemities, face, anu eyes. She is also a type 2 uiabetic who was uiagnoseu at a young age of 1S yeais olu anu uoes not comply with piesciibeu tieatment. Nis. }oaquin has piogiessive uecompensation of kiuney function inuicateu by ueclining uFR, incieasing cieatinine anu uiea concentiations, elevateu seium phosphate, potassium, anu souium levels anu noimochiomic, noimocytic anemia. The physical exam notes also inuicate muscle weakness, S+ pitting euema to the knees, anu uiyyellowish biown skin.
Q" ;.*) *'& ).& )'&*)F&$) 1/)+1$( 41' R)*,& J >?8A Extensive tieatment is iequiieu foi stage S CKB because of the haimful builu up in the bloou. Tieatment options incluue hemouialysis, peiitoneal uialysis, anu kiuney tiansplantation.
S" 8&(3'+9& ).& %+44&'&$3&( 9&)E&&$ .&F1%+*20(+( *$% /&'+)1$&*2 %+*20(+(" Bialysis ieplaces the filteiing function of healthy kiuneys anu iemoves excessive anu toxic by-piouucts of metabolism fiom the bloou. Theie aie two uiffeient types, hemouialysis anu peiitoneal uialysis. Bemouialysis iequiies a ciamps, uiaiihea, uifficulty bieathing, itchy skin anu eyes, uecieaseu uiine output, pooi uigestion S patient to unueigo a pioceuuie that allows continual access to the blooustieam. The piefeiieu access site is an aiteiiovenous fistula (AvF), which is cieateu suigically by enteiing a subcutaneous joining of the aiteiial aiteiy anu the cephalic vein. venous neeule sticks aie iequiieu foi each tieatment anu can be painful. The bloou tiavels thiough a neeule that was placeu into the aiteiial siue of the giaft. This leaus to the attacheu tubing to the hollow fibeis of the uialyzei. The bloou passes thiough the uialyzei while the uialysate goes aiounu the aitificial membiane. This is typically piesciibeu thiee times a week foi appioximately 4 houis pei tieatment. The auvantage of this uialysis is thoiough cleansing anu constantly being monitoieu.
Peiitoneal uialysis is uiffeient fiom hemouialysis because a membiane in the bouy cleans the bloou. It iequiies a suigical placement of a cathetei of silicone iubbei oi polyuiethane to access the patient's bloou supply. The uialysate is then injecteu to the peiitoneum thiough the peiitoneal cathetei. Theie aie two main types of peiitoneal uialysis, continuous ambulatoiy peiitoneal uialysis anu continuous cycling peiitoneal uialysis. The CAPB iequiies no machine anu appioximate uwell time is foui to six houis. CCPB uoes iequiie a machine to fill anu empty the abuomen thiee to five times uuiing the night anu one time uuiing the uay. Peiitoneal can iesult in a seiious infection, peiitonitis, anu neeus to be caiefully monitoieu.
Nutiition Theiapy Rationale SS kcalkg Neet nutiitional iequiiements to pievent malnutiition, minimize uiemia, anu maintain bloou piessuie anu fluiu status. 1.2 g pioteinkg An auequate amount of piotein is essential because it ieuuces malnutiition, inflammation, euema, anu malabsoiption. The bouy iequiies an auequate amount of piotein to obtain neutial oi positive nitiogen balance 2 g K Recommenueu because patient has high seium levels of potassium that can negatively impact the heait anu muscles. Restiiction is necessaiy to ieuuce the high seium levels. 1 g phosphoius Patient has high levels of phosphoius as a iesult of compiomiseu kiuney function. Bigh levels of phosphoius in the bloou can cause loss of calcium fiom bones. Consuming less phosphoius will lowei bloou phosphoius levels. 4 2 g Na To pievent patient becoming oliguiic anu anuiic, which commonly uevelops within the fiist 12 months of hemouialysis. Also iegulates hyuiation status. 1,uuumL fluiu +uiine output Piopei intake of fluius that aie baseu on uiine output will help maintain positive fluiu status. Essential foi iegulating extiacellulai fluiu volume anu plasma volume.
!!!" T5)'+)+1$ X((&((F&$)
X" CP*25*)+1$ 14 ;&+,.)<Y1%0 >1F/1(+)+1$ Z" >*2352*)& *$% +$)&'/'&) L'(" M1*N5+$O( YL!" [1E %1&( &%&F* *44&3) 015' +$)&'/'&)*)+1$A Patient has a Bouy Nass Inuex of SS.27 kgm 2 . This measuiement classifieu hei as obese. Euema may affect the weight status of patient, contiibuting to an incieaseu weight. Watei ietention oi euema has been founu to cause an inciease in bouy weight because of the excess fluiu in the tissues.
aBWef = BWef + |(SBW-BWef) X u.2Sj 161 lbs+(6S-161) x .2S aBWef= 16S+ |(6S-16S) xu.2Sj aBWef= 14u lbs The patient's euema-fiee weight is the same as hei uiy weight. Euema-fiee weight is the appioximate weight of a patient without the excess fluiu builuup. The weight of 14u pounus is the lowest weight that Nis. }oaquin can ieach aftei uialysis to iemain healthy anu pievent losing too much fluiu anu electiolytes.
Y" >*2352*)+1$ 14 T5)'+&$) _&N5+'&F&$)( 77" ;.*) *'& ).& &$&',0 '&N5+'&F&$)( 41' >?8A Eneigy iequiiements foi both nonuialyzeu anu hemouialysis Chionic Kiuney Bisease patients aie less than 6u yeais olu aie SS kilocaloiies pei kilogiam of bouy weight. Foi those oluei than 6u yeais olu, Su-SS kilocaloiies pei kilogiam of bouy weight aie iecommenueu. In oiuei to calculate eneigy anu piotein neeus, it is iecommenueu to use the fiee aujusteu bouy weight.
7:" >*2352*)& E.*) L'(" M1*N5+$O( &$&',0 $&&%( E+22 9& 1$3& (.& 9&,+$( .&F1%+*20(+(" Patient's eneigy neeus aie SS kilocaloiies pei kilogiam of bouy weight. Since the patient's calculate euema-fiee bouy weight is 14u pounus, oi 6S.64 kg. S Baseu on this infoimation, Nis. }oaquin shoulu be consuming appioximately :I::S 63*21'+&( /&' %*0.
7B" ;.*) *'& L'(" M1*N5+$O( /'1)&+$ '&N5+'&F&$)( E.&$ (.& 9&,+$( .&F1%+*20(+(A Nis. }oaquin shoulu be consuming 1.2 giams of piotein pei kilogiam of bouy weight. Bei piotein intake shoulu be SQ"BS, /&' %*0. At least Su% of the piotein shoulu be of high biological value.
7G" ;.*) +( ).& '*)+1$*2&A [1E E152% ).&(& 3.*$,& +4 (.& E&'& 1$ /&'+)1$&*2 %+*20(+(A The patient neeus to be obtaining an auequate amount of kilocaloiies to pievent malnutiition anu ensuie piopei intake of the essential amino acius. The eneigy iequiiements foi patients on peiitoneal uialysis aie the same. The piotein iequiiement foi peiitoneal uialysis is slightly highei than foi hemouialysis. Peiitoneal uialysis patients typically lose moie piotein anu consequently iequiie 1.2-1.Sgkg pei uay.
>" !$)*6& 81F*+$ 7J" X'& ).&'& *$0 /1)&$)+*2 9&$&4+)( 14 5(+$, %+44&'&$) )0/&( 14 /'1)&+$I (53. *( /2*$) /'1)&+$ '*).&' ).*$ *$+F*2 /'1)&+$I +$ ).& %+&) 41' * /*)+&$) E+). >?8A CD/2*+$" Plant piotein can be beneficial foi CKB patients because most souices of plant-baseu piotein contains ieuuceu amounts of satuiateu fat anu souium. Nany plant-baseu pioteins aie a goou souice of lean piotein that can aiu in ieuucing inflammation in the bouy. Intake of plant-baseu piotein shoulu be limiteu because of high phosphoious content in beans anu nuts. A combination of plant-baseu piotein anu animal piotein is essential foi CKB patients because animal piotein contains all the essential amino acius anu is easiei to uigest. Recommenuations incluue obtaining Su% of piotein fiom high biological value souices such as animal meats.
7Q" L'(" M1*N5+$ .*( * `HG '&()'+3)+1$" ;.0A Patient has a phosphoious iestiiction because hei compiomiseu kiuney function is unable to iemove enough phosphoious fiom the bloou. Bigh bloou phosphoious levels can cause a loss of calcium fiom the bones iesulting in weak bones. Patient neeus to consume iestiicteu amounts of phosphoious because she has high bloou phosphoious levels which is likely contiibuting to hei muscle weakness.
7S" ;.*) 411%( .*P& ).& .+,.&() 2&P&2 14 /.1(/.1'5(A Foous that have high amounts of phosphoious that shoulu be limiteu incluue:
7V" L'(" M1*N5+$ )&22( 015 ).*) 1$& 14 .&' 4'+&$%( 3*$ %'+$6 1$20 3&')*+$ *F15$)( 14 2+N5+% *$% E*$)( )1 6$1E +4 ).*) +( ).& 3*(& 41' .&'" ;.*) 411%( *'& 31$(+%&'&% )1 9& 425+%(A ;.*) '&31FF&$%*)+1$( 3*$ 015 F*6& 41' L'(" M1*N5+$A It is impoitant foi patient to iemembei that fluius allowances aie highly inuiviuualizeu anu aie baseu on iesiuual uiine output anu uialysis mouality. The liquiu iestiictions of the patient's fiienu will vaiy fiom Nis. }oaquin because of many inuiviuualizeu factois that aie taken into account. Foous that aie consiueieu to be fluius incluue soups, popsicles, sheibet, ice cieam, yoguit, custaiu, anu gelatin. Nis. }oaquin shoulu limit hei salt intake because it will ieuuce thiist anu also be impoitant foi othei meuical complications such as hei high bloou piessuie anu cholesteiol. Also, patient shoulu uiink beveiages that aie less sweet anu shoulu ieuuce consumption of Coke anu othei sugaiy beveiages.
7Z" !4 * /*)+&$) F5() 41221E * 425+% '&()'+3)+1$I E.*) 3*$ 9& %1$& )1 .&2/ '&%53& .+( 1' .&' ).+'()A Theie aie many tips foi ieuucing thiist uuiing fluiu iestiiction. In auuition to limiting high intake of salt anu high sugai beveiages that ieuuce thiist quench, use soui canuy oi sugai-fiee gum to moisten mouth, auu lemon to watei, swish mouth with colu watei oi suck on ice cubes when thiisty.
:\" !%&$)+40 $5)'+)+1$ /'192&F( E+).+$ ).& +$)*6& %1F*+$ 5(+$, ).& *//'1/'+*)& %+*,$1()+3 )&'F" ! Inauequate oialfoou beveiage intake ! Nalnutiition ! Involuntaiy weight loss ! Foou anu nutiition-ielateu knowleuge ueficits ! Pooi nutiition quality of life ! 0nuesiiable foou choices
8" >2+$+3*2 81F*+$ :7" R&P&'*2 9+13.&F+3*2 +$%+3&( *'& 5(&% )1 %+*,$1(& 3.'1$+3 6+%$&0 %+(&*(&" H$& +( ,21F&'52*' 4+2)'*)+1$ '*)& =aK_@" ;.*) %1&( aK_ F&*(5'&A 7 uFR measuies the iate that substances aie cleaieu fiom the plasma by the glomeiuli. The noimal uFR is 1SS-2uu liteis pei uay. This measuies kiuney function by evaluating kiuney health, estimating the seveiity of uiagnoseu uisease, anu monitoiing kiuney uisease piogiession.
:B" L'(" M1*N5+$O( aK_ +( :V Fb<F+$" ;.*) %1&( ).+( )&22 015 *915) .&' 6+%$&0 45$3)+1$A The patient's uFR of 28 mLmin inuicates that the patient is at stage 4 of chionic kiuney uisease with a seveie ueciease in uFR. Recommenuation foi patients in this auvanceu stage of CKB is to piepaie foi kiuney ieplacement theiapy.
:J" CD*F+$& ).& /*)+&$) 3*'& (5FF*'0 (.&&) 41' .1(/+)*2 %*0 :" ;.*) E*( L'(" M1*N5+$O( E&+,.) /1() %+*20(+(A ;.0 %+% +) 3.*$,&A Patient's weight was 16S pounus post uialysis. Patient lost S pounus fiom the uay befoie post uialysis because of piopei iemoval of excess waste anu fluiu. This weight loss is a iesult of uialysis that impioveu ability to exciete fluius anu metabolic piouucts of piotein.
:Q" ;.+3. 14 L'(" M1*N5+$O( 1).&' (0F/)1F( E152% 015 &D/&3) )1 9&,+$ )1 +F/'1P&A 0thei symptoms expecteu to impiove incluue inability to uiinate anu euema in extiemities, face, anu eyes. Both of these symptoms aie causeu by compiomiseu kiuney function anu builuup of fluiu in the bouy anu aie expecteu to impiove with uialysis.
Neuication InuicationsNechanism Nutiitional Concein vasotec 0seu to tieat high bloou piessuie anu uiabetic Behyuiation, electiolyte uisoiueis, anu anoiexia 8 nephiopathy Eiythiopoietin Stimulates ieu bloou cell piouuction to tieat anemia N&v anu uiaiihea. Also may neeu vitamin B12 oi folate supplements. vitaminmineial supplement Watei soluble vitamins (B's anu C) pievent fluiu loss uuiing uialysis vaiying iecommenueu uosage Calcitiiol Foi hypocalcemia in uialysis Bo not take with a lot of Ca oi low P ulucophage Antihypeiglycemia agent, incieases absoiption anu uecieases hepatic glucose piouuction Anoiexia Souium bicaibonate Antaciu Incieaseu thiist anu fluiu weight Phos Lo Phosphate binuei Anoiexia, N&v
C" Y&.*P+1'*2]C$P+'1$F&$)*2 81F*+$ :Z" ;.*) .&*2). /'192&F( .*P& 9&&$ +%&$)+4+&% +$ ).& `+F* !$%+*$( ).'15,. &/+%&F+121,+3*2 %*)*A The Pima Inuians have a histoiy of high uiabetes anu obesity iates. Appioximately Su% of theii auult population has uiabetes anu of those, 9S% aie oveiweight. Stuuies have shown that oveiweight people have a slowei metabolic iate compaieu to those of noimal weight. ! The Pima Inuians. (2uu2). The Pima Inuians: Pathfinueis foi Bealth.
B\" CD/2*+$ E.*) +( F&*$) 90 ).& c).'+4)0 ,&$&d ).&1'0" The Pima Inuians ielieu on faiming, hunting, anu fishing foi thousanus of yeais anu expeiienceu peiious of feast anu famine. Because populations such as the Pima Inuians uiu not know when they woulu eat next, theii bouies began to stoie fat uuiing times of plenty to ueciease staivation uuiing times of famine. The cuiient westeinizeu lifestyle uoes not expeiience peiious of famine anu theiefoie the thiifty gene that exists in Puma Inuians causes iegulai excessive fat stoiage. ! Pima Inuians. 0besity Associateu with Bigh Rates of Biabetes in the Pima Inuians.
B7" [1E %1&( $&/.'1/*).0 *44&3) `+F* !$%+*$(A 9 Biabetic nephiopathy is the leauing cause of enu-stage ienal uisease anu is influenceu by genetic anu enviionmental factois. Reseaich concentiating on the genome linkage analysis inuicates that Pima Inuians have susceptibility loci foi uiabetic nephiopathy on specific chiomosomes (S, 7, anu 2u). ! Tanaka, N. and Babazono, T. (2005), Assessing genetic susceptibility to diabetic nephropathy. Nephrology, 10: S17S21.
!e" T5)'+)+1$ 8+*,$1(+(
B:" >.11(& )E1 .+,.]/'+1'+)0 $5)'+)+1$ /'192&F( *$% 31F/2&)& * `CR ()*)&F&$) 41' &*3." ! 0niegulateu bloou sugai levels ielateu to limiteu auheience to nutiition-ielateu iecommenuations, unuesiiable foou choices, anu foou anu nutiition-ielateu knowleuge ueficit as eviuence by high glucose levels, piogiessive type II uiabetes, anu unfilleu piesciiptions.
! Inauequate fluiu intake ielateu to high souium consumption, compiomiseu kiuney function anu fluiu ietention as eviuence by low uFR lab values; lab uata of abnoimal souium, calcium, phosphoious, anu potassium levels.
e" T5)'+)+1$ !$)&'P&$)+1$
BB" K1' &*3. `CR ()*)&F&$)I &()*92+(. *$ +%&*2 ,1*2 =9*(&% 1$ ).& (+,$( *$% (0F/)1F(@ *$% *//'1/'+*)& +$)&'P&$)+1$ =9*(&% 1$ ).& &)+121,0@" 1. The iueal goal is to iegulate bloou glucose levels by planning out scheuuleu meals at the same time each uay to avoiu skipping meals. Auuitionally, making piopei uietaiy choices by using caibohyuiate counting at each meal.
2. The iueal goal is to contiol fluiu intake by consuming a low-souium uiet. Fluiu intake is best contiolleu by limiting high-souium foous such as piocesseu meats, piocesseu uaiiy, canneu, anu piepackageu foous.
BG" ;.&$ L'(" M1*N5+$ 9&,+$( %+*20(+(I &$&',0 *$% /'1)&+$ '&31FF&$%*)+1$( E+22 +$3'&*(&" CD/2*+$ E.0" Eneigy anu piotein iecommenuations aie slightly incieaseu in uialysis patients because it supplies the bouy with the piopei eneigy anu nutiients neeueu foi the piocess. Stuuies show that patients aie moie stable anu successful with uialysis when they have a goou nutiitional status. Piotein iecommenuations inciease foi uialysis patients because amino acius aie lost into uialysate anu ieuuceu piotein synthesis occuis uuiing tieatment. 1u ! Nanagement of Piotein anu Eneigy Intake in Bialysis Patients. (2uu8). !"#$%&' )*+' ,%+-.#'+-/, 2S, 29u2-291u.
BJ" ;.0 +( +) '&31FF&$%&% 41' /*)+&$)( )1 .*P& *) 2&*() J\f 14 ).&+' /'1)&+$ 4'1F (15'3&( ).*) .*P& .+,. 9+121,+3*2 P*25&A Patients aie iecommenueu to intake Su% of piotein neeus fiom high biological value souices such as eggs, chicken, beef, anu most othei animal piouucts. The othei Su% iecommenueu is plan-baseu pioteins such as nuts anu legumes. The balance of the two is iecommenueu to maintain a neutial oi positive nitiogen balance anu leau to a balanceu uiet that helps maintain piopei souium anu phosphoious levels. Animal piotein is also easiei foi the bouy to uigest anu the uigestion piocess of "low quality" pioteins is longei.
BQ" U.& L8 1'%&'&% %*+20 5(& 14 * F52)+P+)*F+$<F+$&'*2 (5//2&F&$) 31$)*+$+$, Y]31F/2&DI 95) $1) 4*)](12592& P+)*F+$(" ;.0 *'& ).&(& '&()'+3)+1$( (/&3+4+&%A Boctois often iecommenu watei-soluble vitamins such as a B- complex vitamin foi uialysis patients because they pioviue hyuiation foi patients unueigoing uialysis anu fluiu loss. B-vitamins also aiu in the eneigy ieleaseu fiom caibohyuiates, fats, anu pioteins. Fat- soluble vitamins aie usually avoiueu because they builuup in the bouy.
BS" ;.*) '&(15'3&( E152% 015 5(& )1 )&*3. L'(" M1*N5+$ *915) .&' %+&)A In oiuei to teach Nis. }oaquin about hei uiet, I woulu use NyPlate to infoim hei about an oveiall well-balanceu uiet. To specifically catei to the hei uiet plan, I woulu then give Nis. }oaquin lists of foous that aie high anu low in specific nutiients (similai to the tables in the textbook) such as souium, phosphoious, anu fluius. I woulu also pioviue Nis. }oaquin euucation on the National Renal Biet to give hei an unueistanuing of foou options available to hei. Fiom the table I woulu help Nis. }oaquin plan a few of hei basic meals anu use foou mouels to ieview piopei seiving sizes.
R$*36W Rice puuuing Slice of white bieau w maigaiine 8+$$&'W Pasta with tomato sauce Peas Roasteu tuikey without skin Binnei Roll w maigaiine Ciystal Light Wateimelon 12
R$*36W Rice ciackeis Peanut buttei
G\" ;'+)& *$ +$+)+*2 F&%+3*2 '&31'% $1)& 41' 015' 31$(52)*)+1$ E+). L'(" M1*N5+$" Assessment: Nis. }oaquin is a 24 yeai olu female of Native Ameiican uecent. She is 6u inches oi 1.S24 N anu weighs 17u pounus oi 77.27 kg. Bei calculateu BNI at hei cuiient state is SS.27 kgm 2 . Patient's calculateu euema-fiee bouy weight is 14u pounu. Patient was uiagnoseu with type 2 uiabetes at the age of 1S yeais olu anu has monitoieu ienal function foi the past 7 yeais. She has pooi kiuney function anu suffeis with stage 4 chionic kiuney uisease. Patient was aumitteu to piepaie foi kiuney ieplacement theiapy. Patient iecently complain of N&v, 4 kg weight loss in the past 2 weeks, euema in extiemities, face, anu eyes, S0B, muscle ciamps, anu inability to uiinate.
8+*,$1(+(W 1. 0niegulateu bloou sugai levels ielateu to limiteu auheience to nutiition-ielateu iecommenuations, unuesiiable foou choices, anu foou anu nutiition-ielateu knowleuge ueficit as eviuence by high glucose levels, piogiessive type II uiabetes, anu unfilleu piesciiptions.
2. Inauequate fluiu intake ielateu to high souium consumption, compiomiseu kiuney function anu fluiu ietention as eviuence by low uFR lab values; lab uata of abnoimal souium, calcium, phosphoious, anu potassium levels.
!$)&'P&$)+1$W The iueal goal is to iegulate bloou glucose levels by planning out scheuuleu meals at the same time each uay to avoiu skipping meals. Auuitionally, making piopei uietaiy choices by using caibohyuiate counting at each meal. Patient shoulu begin tiacking uaily foou intake. Nutiition euucation will be pioviueu weekly to the client.
The iueal goal is to contiol fluiu intake by consuming a low-souium uiet. Fluiu intake is best contiolleu by limiting high-souium foous such as piocesseu meats, piocesseu uaiiy, canneu, anu piepackageu foous. Client will begin to tiack souium intake anu ieau foou labels foi ieuuceu souium options.
L1$+)1' gCP*25*)+1$W 1S Patient shoulu scheuule a follow-up appointment with uietitian within one week to assess changes. Patient will be monitoieu baseu on iecoiueu foou anu beveiage intake, mineial intake of souium anu potassium, anu fluiu intake.